申请人:AMERICAN CYANAMID COMPANY
公开号:EP0124791A1
公开(公告)日:1984-11-14
This disclosure describes novel substituted aralkanamidobenzoic acids and analogs thereof. These compounds are useful pharmaceutical agents for ameliorating atherosclerosis by inhibiting the formation and development of atherosclerotic lesions in the arterial wall of mammals.
本公开介绍了新型取代的芳香酰胺基苯甲酸及其类似物。这些化合物可抑制哺乳动物动脉壁动脉粥样硬化病变的形成和发展,是改善动脉粥样硬化的有用药物。